KRAS and metastatic colorectal cancer: The most effective chemotherapy regimens used in the metastatic colorectal cancer setting involve combinations of a fluoropyrimidine with oxaliplatin or irinotecan and a monoclonal antibody targeting VEGF or, in patients with wild-type KRAS, targeting EGFR [5].